Lin Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lin Yang has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Fang Chen
BGI‐Shenzhen Shenzhen China
2 shared publications - Ya Gao
State Key Laboratory of Genome and Multi-Omics Technologies, BGI Research, Shenzhen, China
2 shared publications - Dandan Pu1 shared publication
- Daxi Wang
BGI Research, Beijing, China
1 shared publication - Dongsheng Chen
BGI-shenzhen, Shenzhen, China
1 shared publication - Fang Chen
BGI-Shenzhen
1 shared publication
Latest Publications
- Open Access
Multiple approaches for massively parallel sequencing of HCoV-19 (SARS-CoV-2) genomes directly from clinical samples
COVID-19 has caused a major epidemic worldwide, however, much is yet to be known about the epidemiology and evolution of the virus. One reason is that the challenges underneath sequencing HCoV-19 directly from clinical samples have not been completely tackled. Here we illustrate the application of amplicon and hybrid capture (capture)-based sequencing, as well as ultra-high-throughput metatranscriptomic (meta) sequencing in retrieving complete genomes, inter-individual and intra-individual variations of HCoV-19 from clinical samples covering a range of sample types and viral load. We also examine and compare the bias, sensitivity, accuracy, and other characteristics of these approaches in a comprehensive manner. This is, to date, the first work systematically implements amplicon and capture approaches in sequencing HCoV-19, as well as the first comparative study across methods. Our work offers practical solutions for genome sequencing and analyses of HCoV-19 and other emerging viruses.
Open AccessMultiple approaches for massively parallel sequencing of HCoV-19 (SARS-CoV-2) genomes directly from clinical samples
COVID-19 has caused a major epidemic worldwide, however, much is yet to be known about the epidemiology and evolution of the virus. One reason is that the challenges underneath sequencing HCoV-19 directly from clinical samples have not been completely tackled. Here we illustrate the application of amplicon and hybrid capture (capture)-based sequencing, as well as ultra-high-throughput metatranscriptomic (meta) sequencing in retrieving complete genomes, inter-individual and intra-individual variations of HCoV-19 from clinical samples covering a range of sample types and viral load. We also examine and compare the bias, sensitivity, accuracy, and other characteristics of these approaches in a comprehensive manner. This is, to date, the first work systematically implements amplicon and capture approaches in sequencing HCoV-19, as well as the first comparative study across methods. Our work offers practical solutions for genome sequencing and analyses of HCoV-19 and other emerging viruses.
- Open Access
- 24 January 2019
- Published by Cold Spring Harbor Laboratory in bioRxiv
- p. 529354
FabriEVEs: A dedicated platform for endogenous viral elements in fishes, amphibians, birds, reptiles and invertebrates
Endogenous viral elements (EVEs) are heritable viral deriving elements present in the genomes of other species. As DNA ‘fossils’ left by ancient viruses, EVEs were used to infer the characteristics of extinct viruses. EVEs in mammals have been well classified by several databases, however, EVEs in non-mammalian organisms are poorly documented. Here, we report FabriEVEs (http://tfbsbank.co.uk/FabriEVEs), the first dedicated and comprehensive online platform for the collection, classification and annotation of EVEs in fishes, amphibians, birds, reptiles and invertebrates. In total, nearly 1.5 million EVEs from 82 species deriving from class I (dsDNA), II (ssDNA), III (dsRNA), IV (positive ssRNA), V (negative ssRNA), VI (ssRNA-RT) and VII (dsDNA-RT) viruses were recorded in FabriEVEs, accompanying with comprehensive annotation including the species name, location, genomic features, virus family and associated literature. Flexible and powerful query options were provided to pinpoint desired EVEs. Furthermore, FabriEVEs provides free access to all EVEs data in case users need to download them for further analysis. Taken together, our database provided systematic classification and annotation of EVEs in non-mammal species, which paves the way for comparative analysis of EVEs and throws light upon the co-evolution of EVEs and their hosts.
- 24 January 2019
- Published by Cold Spring Harbor Laboratory in bioRxiv
- p. 529354
Open AccessFabriEVEs: A dedicated platform for endogenous viral elements in fishes, amphibians, birds, reptiles and invertebrates
Endogenous viral elements (EVEs) are heritable viral deriving elements present in the genomes of other species. As DNA ‘fossils’ left by ancient viruses, EVEs were used to infer the characteristics of extinct viruses. EVEs in mammals have been well classified by several databases, however, EVEs in non-mammalian organisms are poorly documented. Here, we report FabriEVEs (http://tfbsbank.co.uk/FabriEVEs), the first dedicated and comprehensive online platform for the collection, classification and annotation of EVEs in fishes, amphibians, birds, reptiles and invertebrates. In total, nearly 1.5 million EVEs from 82 species deriving from class I (dsDNA), II (ssDNA), III (dsRNA), IV (positive ssRNA), V (negative ssRNA), VI (ssRNA-RT) and VII (dsDNA-RT) viruses were recorded in FabriEVEs, accompanying with comprehensive annotation including the species name, location, genomic features, virus family and associated literature. Flexible and powerful query options were provided to pinpoint desired EVEs. Furthermore, FabriEVEs provides free access to all EVEs data in case users need to download them for further analysis. Taken together, our database provided systematic classification and annotation of EVEs in non-mammal species, which paves the way for comparative analysis of EVEs and throws light upon the co-evolution of EVEs and their hosts.
- Open Access
Noninvasive prenatal detection of fetal trisomy and single gene disease by shotgun sequencing of placenta originated exosome DNA: a proof-of-concept validation
Background: During human pregnancy, Placental trophectoderm cells can release exosomes into maternal circulation. Trophoblast cells also give rise to cell-free DNA (cfDNA) and has been used for noninvasive prenatal screening for chromosomal aneuploidy. We intended to prove the existence of exosomal DNA (exoDNA) in the exosomes of maternal blood and compared exoDNA with plasma cfDNA in terms of genome distribution, fragment length, and the possibility of detecting genetic diseases. Methods: Maternal blood from 20 euploid pregnancies, 9 T21 pregnancies, 3 T18 pregnancies, 1 T13 pregnancy and 2 pregnancies with FGFR3 mutations were obtained. Exosomes enriched from maternal plasma were confirmed by transmission electronic microscopy (TEM), western blotting and flow cytometry. ExoDNA was extracted and its fetal origin was confirmed by realtime fluorescence quantitative PCR(Q-PCR). Besides, exoDNA content was uncovered by Q-PCR. To characterize exoDNA and compare with cfDNA, pair-end whole genome sequencing was performed. Lastly, the fetal risk of genetic diseases was analyzed using the exoDNA sequencing data. Results: ExoDNA span on all 23 pairs of chromosomes and mitochondria, sharing a similar distribution pattern and higher GC content comparing with cfDNA. ExoDNA showed shorter fragments yet lower fetal fraction than cfDNA. ExoDNA could be used to determine fetal gender correctly, and all trisomies as well as de novo FGFR3 mutations. Conclusions: We proved that fetal exoDNA could be identified in the exosomes extracted from maternal plasma. ExoDNA shared some similar features to cfDNA and could potentially be used to detect genetic diseases in fetus.
Open AccessNoninvasive prenatal detection of fetal trisomy and single gene disease by shotgun sequencing of placenta originated exosome DNA: a proof-of-concept validation
Background: During human pregnancy, Placental trophectoderm cells can release exosomes into maternal circulation. Trophoblast cells also give rise to cell-free DNA (cfDNA) and has been used for noninvasive prenatal screening for chromosomal aneuploidy. We intended to prove the existence of exosomal DNA (exoDNA) in the exosomes of maternal blood and compared exoDNA with plasma cfDNA in terms of genome distribution, fragment length, and the possibility of detecting genetic diseases. Methods: Maternal blood from 20 euploid pregnancies, 9 T21 pregnancies, 3 T18 pregnancies, 1 T13 pregnancy and 2 pregnancies with FGFR3 mutations were obtained. Exosomes enriched from maternal plasma were confirmed by transmission electronic microscopy (TEM), western blotting and flow cytometry. ExoDNA was extracted and its fetal origin was confirmed by realtime fluorescence quantitative PCR(Q-PCR). Besides, exoDNA content was uncovered by Q-PCR. To characterize exoDNA and compare with cfDNA, pair-end whole genome sequencing was performed. Lastly, the fetal risk of genetic diseases was analyzed using the exoDNA sequencing data. Results: ExoDNA span on all 23 pairs of chromosomes and mitochondria, sharing a similar distribution pattern and higher GC content comparing with cfDNA. ExoDNA showed shorter fragments yet lower fetal fraction than cfDNA. ExoDNA could be used to determine fetal gender correctly, and all trisomies as well as de novo FGFR3 mutations. Conclusions: We proved that fetal exoDNA could be identified in the exosomes extracted from maternal plasma. ExoDNA shared some similar features to cfDNA and could potentially be used to detect genetic diseases in fetus.